Clinical trials
Myocardial Ischemia trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2021 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 9 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ministry of Health, Brazil | 5 |
| Abbott Medical Devices | 3 |
| Instituto de Cardiologia do Rio Grande do Sul | 3 |
| Hospital de Clinicas de Porto Alegre | 2 |
| Alexandra Cristina Senegaglia | 1 |
| Biotronik AG | 1 |
| Federal University of Rio Grande do Sul | 1 |
| Federal University of São Paulo | 1 |
| Johns Hopkins University | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Ischemia | 25 |
| Coronary Artery Disease | 13 |
| Cardiovascular Diseases | 5 |
| Coronary Disease | 5 |
| Coronary Stenosis | 5 |
| Coronary Restenosis | 4 |
| Myocardial Infarction | 4 |
| Angina Pectoris | 3 |
| Heart Diseases | 3 |
| Vascular Diseases | 3 |
Trials
Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.